Format
Sort by
Items per page

Send to

Choose Destination

Best matches for KETOCONAZOLE/PD:

The Rise and Fall of Oral Ketoconazole. Gupta AK et al. J Cutan Med Surg. (2015)

Liver injury associated with ketoconazole: review of the published evidence. Greenblatt HK et al. J Clin Pharmacol. (2014)

Drug safety assessment of oral formulations of ketoconazole. Gupta AK et al. Expert Opin Drug Saf. (2015)

Search results

Items: 1 to 20 of 3259

1.

Hepatic safety of ketoconazole in Cushing's syndrome: results of a Compassionate Use Programme in France.

Young J, Bertherat J, Vantyghem MC, Chabre O, Senoussi S, Chadarevian R, Castinetti F; Compassionalte use Programme.

Eur J Endocrinol. 2018 May;178(5):447-458. doi: 10.1530/EJE-17-0886. Epub 2018 Feb 22.

PMID:
29472378
2.

5-hydroxymethyl-2-furaldehyde from marine bacterium Bacillus subtilis inhibits biofilm and virulence of Candida albicans.

Subramenium GA, Swetha TK, Iyer PM, Balamurugan K, Pandian SK.

Microbiol Res. 2018 Mar;207:19-32. doi: 10.1016/j.micres.2017.11.002. Epub 2017 Nov 8.

PMID:
29458854
3.

Long-term pubic dermatitis diagnosed as white piedra.

Landero J.

Cutis. 2017 Dec;100(6):448-450.

PMID:
29360892
4.

Physiological based pharmacokinetic modeling to estimate in vivo Ki of ketoconazole on renal P-gp using human drug-drug interaction study result of fesoterodine and ketoconazole.

Oishi M, Takano Y, Torita Y, Malhotra B, Chiba K.

Drug Metab Pharmacokinet. 2018 Feb;33(1):90-95. doi: 10.1016/j.dmpk.2017.11.005. Epub 2017 Nov 15.

PMID:
29338933
5.

Effects of ketoconazole on cyclophosphamide metabolism: evaluation of CYP3A4 inhibition effect using the in vitro and in vivo models.

Yang L, Yan C, Zhang F, Jiang B, Gao S, Liang Y, Huang L, Chen W.

Exp Anim. 2018 Feb 9;67(1):71-82. doi: 10.1538/expanim.17-0048. Epub 2017 Nov 13.

6.

Formulation and evaluation of selected transmucosal dosage forms containing a double fixed-dose of acyclovir and ketoconazole.

Viljoen JM, Botes D, Steenekamp JH.

Eur J Pharm Sci. 2018 Jan 1;111:503-513. doi: 10.1016/j.ejps.2017.10.033. Epub 2017 Nov 5.

PMID:
29080856
7.

Pharmacokinetic Evaluation of the Interactions of Amenamevir (ASP2151) with Ketoconazole, Rifampicin, Midazolam, and Warfarin in Healthy Adults.

Kusawake T, den Adel M, Groenendaal-van de Meent D, Garcia-Hernandez A, Takada A, Kato K, Ohtsu Y, Katashima M.

Adv Ther. 2017 Nov;34(11):2466-2480. doi: 10.1007/s12325-017-0634-4. Epub 2017 Oct 26.

8.

Effects of Ketoconazole on the Pharmacokinetics of Mifepristone, a Competitive Glucocorticoid Receptor Antagonist, in Healthy Men.

Nguyen D, Mizne S.

Adv Ther. 2017 Oct;34(10):2371-2385. doi: 10.1007/s12325-017-0621-9. Epub 2017 Oct 11.

9.

Efficacy of azole therapy for tegumentary leishmaniasis: A systematic review and meta-analysis.

Galvão EL, Rabello A, Cota GF.

PLoS One. 2017 Oct 9;12(10):e0186117. doi: 10.1371/journal.pone.0186117. eCollection 2017. Review.

10.

In silico analysis of cytochrome P450 monooxygenases in chronic granulomatous infectious fungus Sporothrix schenckii: Special focus on CYP51.

Matowane RG, Wieteska L, Bamal HD, Kgosiemang IKR, Van Wyk M, Manume NA, Abdalla SMH, Mashele SS, Gront D, Syed K.

Biochim Biophys Acta. 2018 Jan;1866(1):166-177. doi: 10.1016/j.bbapap.2017.10.003. Epub 2017 Oct 5.

PMID:
28989052
11.

Prediction of drug-drug interactions using physiologically-based pharmacokinetic models of CYP450 modulators included in Simcyp software.

Marsousi N, Desmeules JA, Rudaz S, Daali Y.

Biopharm Drug Dispos. 2018 Jan;39(1):3-17. doi: 10.1002/bdd.2107. Epub 2017 Nov 20.

PMID:
28960401
12.

Comparison of Oral Voriconazole Versus Oral Ketoconazole as an Adjunct to Topical Natamycin in Severe Fungal Keratitis: A Randomized Controlled Trial.

Sharma N, Singhal D, Maharana PK, Sinha R, Agarwal T, Upadhyay AD, Velpandian T, Satpathy G, Titiyal JS.

Cornea. 2017 Dec;36(12):1521-1527. doi: 10.1097/ICO.0000000000001365.

PMID:
28902012
13.

Putative contact ketoconazole shampoo-triggered pemphigus foliaceus in a dog.

Sung HJ, Yoon IH, Kim JH.

Can Vet J. 2017 Sep;58(9):914-918.

14.

Interaction of erythromycin and ketoconazole on the neurological, biochemical and behavioral responses in crucian carp.

Liu J, Cai Y, Lu G, Dan X, Wu D, Yan Z.

Environ Toxicol Pharmacol. 2017 Oct;55:14-19. doi: 10.1016/j.etap.2017.08.002. Epub 2017 Aug 7.

PMID:
28802958
15.

Model-Based Analysis of Biopharmaceutic Experiments To Improve Mechanistic Oral Absorption Modeling: An Integrated in Vitro in Vivo Extrapolation Perspective Using Ketoconazole as a Model Drug.

Pathak SM, Ruff A, Kostewicz ES, Patel N, Turner DB, Jamei M.

Mol Pharm. 2017 Dec 4;14(12):4305-4320. doi: 10.1021/acs.molpharmaceut.7b00406. Epub 2017 Aug 25.

16.

Study of Rheology and Polymer Adsorption Onto Drug Nanoparticles in Pharmaceutical Suspensions Produced by Nanomilling.

Negrini R, Aleandri S, Kuentz M.

J Pharm Sci. 2017 Nov;106(11):3395-3401. doi: 10.1016/j.xphs.2017.07.006. Epub 2017 Jul 18.

PMID:
28732711
17.

Mechanism-based risk assessment strategy for drug-induced cholestasis using the transcriptional benchmark dose derived by toxicogenomics.

Kawamoto T, Ito Y, Morita O, Honda H.

J Toxicol Sci. 2017;42(4):427-436. doi: 10.2131/jts.42.427.

18.

Silver nanoparticles from Pilimelia columellifera subsp. pallida SL19 strain demonstrated antifungal activity against fungi causing superficial mycoses.

Wypij M, Czarnecka J, Dahm H, Rai M, Golinska P.

J Basic Microbiol. 2017 Sep;57(9):793-800. doi: 10.1002/jobm.201700121. Epub 2017 Jul 3.

PMID:
28670763
19.

A polymorphism in the CYP17A1 gene influences the therapeutic response to steroidogenesis inhibitors in Cushing's syndrome.

Valassi E, Aulinas A, Glad CA, Johannsson G, Ragnarsson O, Webb SM.

Clin Endocrinol (Oxf). 2017 Nov;87(5):433-439. doi: 10.1111/cen.13414. Epub 2017 Jul 31.

PMID:
28665508
20.

In vitro additive interaction between ketoconazole and antimony against intramacrophage Leishmania (Leishmania) amazonensis amastigotes.

Nunes DCO, Bispo-da-Silva LB, Napolitano DR, Costa MS, Figueira MMNR, Rodrigues RS, Rodrigues VM, Yoneyama KAG.

PLoS One. 2017 Jun 29;12(6):e0180530. doi: 10.1371/journal.pone.0180530. eCollection 2017.

Supplemental Content

Loading ...
Support Center